First Epoetin Alfa Biosimilar Approved in the US First Epoetin Alfa Biosimilar Approved in the US

The first biosimilar erythropoiesis-stimulating agent has received FDA approval for a number of indications. It is expected to be less costly than the patented biologic.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news